g***e
发帖数: 1256 | 1 ALXＡ 这几天暴量升降。我从另外的论坛信息中先注意到的，然后看了看消息，我觉
得握住了应该很有戏。它申请批准的药应该很可能批，ＦＤＡ建议用量减一次哦，而且
似乎批准他的新药单独用。如果他们再次申请，就照着ＦＤＡ的建议做，应该没有理由
拒绝吧。 |
j******y
发帖数: 700 | |
m*****o
发帖数: 854 | 3 被套了； 感觉庄家自己判断错了， 前几天大甩卖掉了， 可能短期内不会拉起来吧
。
现自己拿着吧； 大牛有什么好建议。股票我智商不行啊。
【在 g***e 的大作中提到】
: ALXＡ 这几天暴量升降。我从另外的论坛信息中先注意到的，然后看了看消息，我觉
: 得握住了应该很有戏。它申请批准的药应该很可能批，ＦＤＡ建议用量减一次哦，而且
: 似乎批准他的新药单独用。如果他们再次申请，就照着ＦＤＡ的建议做，应该没有理由
: 拒绝吧。
|
d******8
发帖数: 1972 | 4 Alexza Pharmaceuticals: Forward Looking Approval Catalyst In Play
http://seekingalpha.com/article/313829-alexza-pharmaceuticals-f
Last week, shares of Alexza lost 47% of their value after an internal FDA
Review found that their inhaled antipsychotic might pose fatal lung risks.
The report, which was released on Wednesday was enough to send speculators
packing. (See our previous report) Shares of the company surged after the
advisory committee voted 9/8/1 (yes/no/abstain) on the issue.
"We view the recommendations by the PDAC today as another step forward in
the development of ADASUVE," stated Thomas B. King, President and Chief
Executive Officer of Alexza Pharmaceuticals. "We appreciate the Advisory
Committee's recognition of agitation as a serious and underappreciated
symptom of schizophrenia and bipolar disorder. If approved, we believe
ADASUVE represents a valuable treatment option for patients and physicians
alike. We look forward to continuing to work toward our goal of bringing
ADASUVE to market in 2012."
Adasuve would be the first product for Mountain View, California-based
Alexza. The therapy uses an inhalation device developed by the company to
deliver a vaporized form of the 36- year-old antipsychotic drug loxapine to
the lungs for rapid absorption into the bloodstream. The FDA, which doesn’t
have to follow the panel’s recommendation, aims to decide on the product
by Feb. 4. We anticipate that after the trading action settles, shares of
the company will once again begin to rise in anticipation of that binary
event in early February. |
g***e
发帖数: 1256 | |
g***e
发帖数: 1256 | 6 yes, I read this one. I think it is very promising of the approval from FDA.
It is even better than the chance of ARNA.
【在 d******8 的大作中提到】
: Alexza Pharmaceuticals: Forward Looking Approval Catalyst In Play
: http://seekingalpha.com/article/313829-alexza-pharmaceuticals-f
: Last week, shares of Alexza lost 47% of their value after an internal FDA
: Review found that their inhaled antipsychotic might pose fatal lung risks.
: The report, which was released on Wednesday was enough to send speculators
: packing. (See our previous report) Shares of the company surged after the
: advisory committee voted 9/8/1 (yes/no/abstain) on the issue.
: "We view the recommendations by the PDAC today as another step forward in
: the development of ADASUVE," stated Thomas B. King, President and Chief
: Executive Officer of Alexza Pharmaceuticals. "We appreciate the Advisory
|
j*****7
发帖数: 4348 | 7 No good. Safety concern. |
s*******1
发帖数: 1644 | |
j******y
发帖数: 700 | 9 unloading
【在 s*******1 的大作中提到】
: 高位被套，求解
: 现在暴涨然后暴跌，mm什么意思
|
g***e
发帖数: 1256 | 10 all drugs are toxic, only the dose amount counts.
【在 j*****7 的大作中提到】
: No good. Safety concern.
|
|
|
j******y
发帖数: 700 | 11 one problem with the drug dose is that, if the drug dose is reduced, does
it still effective? that's a big question. I do not think it would be
true, since ALXA they must have done the optimization before-hand and they
found the most effective dose is one which would cause risk...
【在 g***e 的大作中提到】
: ALXＡ 这几天暴量升降。我从另外的论坛信息中先注意到的，然后看了看消息，我觉
: 得握住了应该很有戏。它申请批准的药应该很可能批，ＦＤＡ建议用量减一次哦，而且
: 似乎批准他的新药单独用。如果他们再次申请，就照着ＦＤＡ的建议做，应该没有理由
: 拒绝吧。
|
s*******1
发帖数: 1644 | |
g***e
发帖数: 1256 | 13 Yes, you are right. The reduced dose may not be useful. Thanks!!!
【在 j******y 的大作中提到】
: one problem with the drug dose is that, if the drug dose is reduced, does
: it still effective? that's a big question. I do not think it would be
: true, since ALXA they must have done the optimization before-hand and they
: found the most effective dose is one which would cause risk...
|
s*******1
发帖数: 1644 | 14
FDA.
arna 怎么说？
我看中的为什么都要挂的
【在 g***e 的大作中提到】
: yes, I read this one. I think it is very promising of the approval from FDA.
: It is even better than the chance of ARNA.
|
m******u
发帖数: 340 | 15 The efficacy has been demonstrated with current dosage. The concern is
about time interval for repeated dose. There is not sufficent data to back
up the original claim filed by Alexza, but the reduced dosing frequency is
supported.
【在 g***e 的大作中提到】
: Yes, you are right. The reduced dose may not be useful. Thanks!!!
|
s*******1
发帖数: 1644 | |
K********g
发帖数: 9389 | 17 ALXA这个破公司我从来就不看好，这次终于寿终正寝了。
【在 g***e 的大作中提到】
: ALXＡ 这几天暴量升降。我从另外的论坛信息中先注意到的，然后看了看消息，我觉
: 得握住了应该很有戏。它申请批准的药应该很可能批，ＦＤＡ建议用量减一次哦，而且
: 似乎批准他的新药单独用。如果他们再次申请，就照着ＦＤＡ的建议做，应该没有理由
: 拒绝吧。
|
s*******1
发帖数: 1644 | 18
那arna呢
麻烦解读下谢谢
【在 K********g 的大作中提到】
: ALXA这个破公司我从来就不看好，这次终于寿终正寝了。
|
j*****7
发帖数: 4348 | 19 退一万步说，就算FDA给过了， 这个device能有什么商业前途。 |
g***e
发帖数: 1256 | 20 谢谢大牛，你怎么看ＥＸＡＭ? ＡＲＮＡ?
【在 K********g 的大作中提到】
: ALXA这个破公司我从来就不看好，这次终于寿终正寝了。
|
